Effect on posterior capsule opacification of topical diclofenac sodium vs dexamethasone phosphate after cataract surgery

Annals of Ophthalmology

Volumn 34, Issue 2, 2002, Pages 142-147

  Barequet, Irina S ^a   Wygnanski Jaffe, Tamara ^a   Sachs, Dan ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; DICLOFENAC;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL;

EID: 0036064369     PISSN: 15304086     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12009-002-0044-2     Document Type: Article

References (32)

1. Posterior capsule opacification
2. Surgical prevention of posterior capsule opacification. Part 1: Progress in eliminating this complication of cataract surgery
3. Surgical prevention of posterior capsule opacification. Part 2: Enhancement of cortical cleanup by focusing on hydrodissection
4. Truncated edge design, dysphotopsia, and inhibition of posterior capsule opacification
5. Surgical prevention of posterior capsule opacification. Part 3: Intraocular lens optic barrier effect as a second of defense
6. Intraocular lens bioactivity tested using rabbit corneal tissue cultures
7. Adhesion of soluble fibronectin, laminin, and collagen type IV to intraocular lens materials
8. Effect ofintraocular lens design on migration of lens epithelial cells onto the posterior capsule
9. Digital retroilluminated photography to analyze posterior capsule opacification in eyes with intraocular lenses
10. Lens epithelial cell regression on the posterior capsule with different intraocular lens materials
11. Relationship between intraocular lens biomaterials and posterior capsule opacification
12. In vitro inhibition of lens epithelial cell proliferation and migration
13. Inhibition of migrating lens epithelial cells by blocking the adhesion molecule integrin: A preliminary report
14. Heparin eyedrops to prevent posterior capsule opacification
15. Inhibition of posterior capsule opacification: The effect of colchicine in a sustained drug delivery system
16. Inhibition of posterior capsule opacification by an intraocular-lens-bound sustained drug delivery system: An experimental animal study and literature review
17. Use of polylysinesaporin conjugate to prevent posterior caspule opacification
18. Posterior capsule opacification after phacoemulsification in patients with diabetes mellitus
19. Efficacy of diclofenac ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation
20. Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgery
21. A comparison of topical diclofenac with prednisone for postcataract inflammation
22. Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture
23. Effects of diclofenac sodium and indomethacin on proliferation and collagen synthesis of lens epithelial cells in vitro
24. Long-term efficacy of diclofenac sodium after PEA and IOL surgery
25. The gliding nucleus
26. Photographic image analysis system of posterior capsule opacification
27. A systematic overview of the incidence of posterior capsule opacification
28. Cellular reaction on the surface of intraocular lenses removed from human eyes
29. Lens epithelial cell outgrowth and matrix formation on intraocular lenses in rabbit eyes
30. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts
31. Effect of intraocular sustained release of indomethacin on postoperative inflammation and posterior capsule opacification
32. Effect of indomethacin-coated posterior chamber intraocular lenses on postoperative inflammation and posterior capsule opacification